Preventive Medicine encompasses a wide range of strategies aimed at preventing disease, promoting health, and prolonging life. Vaccination is one of the most powerful tools in preventive medicine, as it helps to protect individuals and populations from infectious diseases by stimulating the immune system to produce a protective response against specific pathogens.
Vaccines work by introducing a harmless form of the pathogen or its components into the body, triggering the immune system to recognize and mount a defense against the infectious agent. This immune response results in the production of antibodies and memory cells that provide long-lasting protection against future infections.
Vaccines have been instrumental in reducing the burden of infectious diseases worldwide, preventing millions of cases of illness, disability, and death each year. Diseases such as smallpox, polio, measles, and tetanus have been either eliminated or significantly controlled through widespread vaccination efforts. In addition to preventing infectious diseases, vaccines also offer other benefits to individuals and society as a whole. They can reduce healthcare costs by preventing expensive medical treatments and hospitalizations associated with vaccine-preventable diseases. They also help to protect vulnerable populations, such as infants, elderly individuals, and those with weakened immune systems, who may be at higher risk of complications from infectious diseases.
Vaccination programs are typically implemented through national or regional immunization schedules, which recommend the timing and doses of vaccines for different age groups and populations. These schedules are based on scientific evidence, epidemiological data, and public health priorities, and are regularly updated to reflect changes in disease prevalence, vaccine effectiveness, and emerging infectious threats. Despite the overwhelming success of vaccination programs, challenges remain in achieving and maintaining high vaccine coverage rates. Vaccine hesitancy, misinformation, and access barriers can all contribute to suboptimal vaccine uptake, leading to outbreaks of vaccine-preventable diseases and undermining public health efforts.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia